Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ALXO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Wednesday for ALX Oncology Holdings Inc. stock after gaining 1.97%
(Updated on Mar 27, 2024)

Sell candidate since Mar 11, 2024 Loss -15.23% PDF

The ALX Oncology Holdings Inc. stock price gained 1.97% on the last trading day (Wednesday, 27th Mar 2024), rising from $11.19 to $11.41. During the last trading day the stock fluctuated 6.48% from a day low at $10.95 to a day high of $11.66. The price has been going up and down for this period, and there has been a -1.64% loss for the last 2 weeks. Volume fell on the last day by -57 thousand shares and in total, 197 thousand shares were bought and sold for approximately $2.25 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $10.74 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -10.09% during the next 3 months and, with a 90% probability hold a price between $9.66 and $14.36 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ALXO Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, March 18, 2024, and so far it has risen 4.20%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The ALX Oncology Holdings Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $11.73 and $14.01. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for ALX Oncology Holdings Inc. stock

ALX Oncology Holdings Inc. finds support from accumulated volume at $11.30 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.710 between high and low, or 6.48%. For the last week, the stock has had daily average volatility of 6.32%.

ALX Oncology Holdings Inc. is oversold on RSI14 (22). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ALXO) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect ALX Oncology Holdings Inc. to open at $11.34, and during the day (based on 14 day Average True Range), to move between $10.41 and $12.41, which gives a possible trading interval of +/-$1.00 (+/-8.77%) up or down from last closing price. If ALX Oncology Holdings Inc. takes out the full calculated possible swing range there will be an estimated 17.53% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $11.30 (0.96%) than the resistance at $12.37 (8.41%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is ALX Oncology Holdings Inc. stock A Buy?

ALX Oncology Holdings Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.226 Sell Candidate Unchanged

Predicted Opening Price for ALX Oncology Holdings Inc. of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$11.34 ( 0.613%) $11.41

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ALXO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 12.05 5.61 %
R2 11.78 3.23 %
R1 11.61 1.76 %
Current price: 11.41
Support S1 11.07 -2.99 %
S2 10.90 -4.46 %
S3 10.63 -6.84 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 13.46 17.97 %
R2 12.51 9.64 %
R1 12.37 8.41 %
Current price 11.41
Support S1 11.30 -0.96%
S2 11.15 -2.28%
S3 10.95 -4.03%

FAQ

What is the symbol for ALX Oncology Holdings Inc. Stock and on which exchange is it traded?
The symbol for ALX Oncology Holdings Inc. is ALXO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ALX Oncology Holdings Inc. Stock?
ALX Oncology Holdings Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy ALX Oncology Holdings Inc. Stock?
ALX Oncology Holdings Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ALX Oncology Holdings Inc. Stock.

What's the current price of ALX Oncology Holdings Inc. Stock?
As of the end of day on the 2024-03-27, the price of an ALX Oncology Holdings Inc. (ALXO) share was $11.41.

What is the 52-week high and low for ALX Oncology Holdings Inc. Stock?
The 52-week high for ALX Oncology Holdings Inc. Stock is $17.42 and the 52-week low is $3.94.

What is the market capitalization of ALX Oncology Holdings Inc. Stock?
As of the 2024-03-27, the market capitalization of ALX Oncology Holdings Inc. is 561.202M.

When is the next earnings date for ALX Oncology Holdings Inc.?
The upcoming earnings date for ALX Oncology Holdings Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About ALX Oncology Holdings Inc.

ALX Oncology Holdings. ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hodgkin's lymphoma, as well as a range of solid tumor indications, including head and neck squamous cell c... ALXO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT